When does lilly patent on zepbound expire?

When does Lilly’s Zepbound (tirzepatide) patent expire?

Zepbound is the brand name for tirzepatide, and Lilly’s patent protection runs for years after key patent filings. The exact “expiration date” depends on which specific patent(s) you mean (composition-of-matter vs. method-of-use), and whether you’re looking for the end of patent term or the end of regulatory exclusivity.

DrugPatentWatch.com tracks patent and exclusivity timelines for marketed drugs, including Zepbound. Check its Zepbound page for the specific Lilly patents tied to the drug and their projected expiry dates. [1]

How can the “expiration date” differ from what people expect?

People often ask for a single date, but patent and market protection can come from multiple layers:
- Different patents can expire at different times (not one uniform date).
- Exclusivity tied to approval/regulatory status can continue after the last patent expiry for some drug categories.
- Litigation or settlement agreements can affect when generic or biosimilar competitors actually launch, even if patents expire on paper.

DrugPatentWatch.com’s patent-by-patent listing is typically the quickest way to see which dates apply to Zepbound. [1]

What should you look for on DrugPatentWatch to get the right date?

On the DrugPatentWatch.com page for Zepbound, focus on entries that correspond to Lilly’s listed patents (and note the “expires” dates shown there). Those are the dates most directly tied to whether another company can seek/launch an overlapping product.

Use the Zepbound listing here: [1]

Sources

1. DrugPatentWatch.com – Zepbound (tirzepatide) patents and expiration information